Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      La Facultad de Medicina de Yale recibe una donación de USD 10 millones para curar la diabetes tipo 1

      • USA - English
      • USA - Traditional Chinese
      • USA - Traditional Chinese
      Yale School of Medicine Logo

      News provided by

      Yale School of Medicine

      Nov 17, 2026, 10:30 ET

      Share this article

      Share this article


      NEW HAVEN, Connecticut, 17 de noviembre de 2026 /PRNewswire-HISPANIC PR WIRE/ -- La Facultad de Medicina de Yale recibió una donación de USD 10 millones destinada a financiar un programa de investigación de cinco años, con un equipo multidisciplinario de científicos, cuyo objetivo es revertir y, en última instancia, curar la diabetes tipo 1.

      La donación fue realizada por Anastasia e Igor Bukhman, a través de la Fundación Bukhman.

      "Estamos agradecidos con Anastasia e Igor Bukhman por su generosidad y por la confianza que han depositado en nuestros investigadores", dice Nancy J. Brown, MD, decana Jean y David W. Wallace de la Facultad de Medicina de Yale. "Este apoyo filantrópico permitirá a estos investigadores transformar la forma en que se trata la diabetes tipo 1, mediante el desarrollo de terapias de precisión capaces de modificar el curso de la enfermedad y, finalmente, prevenirla."

      Para la familia Bukhman, la diabetes es un asunto personal que afecta a sus miembros, incluida la hija de Anastasia, a quien le diagnosticaron la enfermedad a los 3 años. "Es una afección que ha estado presente en nuestra familia durante mucho tiempo", dice, "y que ha desempeñado un papel fundamental en la definición del trabajo que realizamos hoy en día".

      Kevan Herold, MD, profesor C.N.H. Long de inmunobiología y medicina (endocrinología), lidera una línea de investigación centrada en detener el ataque inmunitario contra las células beta y desarrollar estrategias de tratamiento personalizadas según el perfil genético e inmunológico de cada paciente.

      "Esta donación financia numerosos proyectos centrados en detener la patogénesis inmunomediada de la diabetes tipo 1 y restaurar las células beta productoras de insulina perdidas", afirma Herold. "La investigación está orientada a un objetivo concreto, y ese objetivo es la prevención o la reversión de la enfermedad. Los estudios desarrollarán estrategias de tratamiento personalizadas que incluirán el análisis de firmas génicas, características inmunológicas y células beta de personas con diabetes o en riesgo de desarrollarla."

      Además de Herold, el programa apoyará el trabajo de los siguientes científicos:

      • Esen Sefik, PhD, profesor asistente de inmunobiología, contribuye con investigaciones que fortalecen el modelado de enfermedades y caracterizan la variación entre las células inmunitarias de los pacientes.
      • Richard Flavell, PhD, profesor Sterling de inmunobiología, aporta experiencia en el desarrollo de ratones modificados genéticamente para estudiar el sistema inmunitario. 
      • Nikhil Joshi, PhD, profesor de inmunobiología y codirector de Inmunología del Cáncer en el Centro Oncológico de Yale, aplica conocimientos de la inmunología oncológica al estudio del comportamiento y la tolerancia de las células inmunitarias en la diabetes tipo 1.
      • Richard Kibbey, MD, PhD, profesor Ensign de Medicina (Endocrinología y Metabolismo) y profesor de fisiología molecular y celular, se centra en la biología de las células beta, así como en la supervivencia y mejora funcional de las células de reemplazo productoras de insulina.
      • John Tsang, PhD, profesor Anthony N. Brady de inmunobiología e ingeniería biomédica y director del Centro de Sistemas e Ingeniería Inmunológica de Yale, aplica modelos computacionales para analizar datos inmunitarios complejos capaces de identificar características específicas de cada paciente en todo el programa.

      Acerca de la Facultad de Medicina de Yale

      La Facultad de Medicina de Yale forma a líderes en el ámbito de la medicina y la ciencia, fomentando la curiosidad y el espíritu crítico. Es líder mundial en investigación biomédica, atención clínica y formación médica. Con más de 1700 médicos, Yale brinda atención empática y humanizada a pacientes de todo el mundo. El Sistema de Educación Médica de Yale pone énfasis en el pensamiento crítico y la investigación independiente, preparando a los futuros líderes de la medicina académica.

      FUENTE Yale School of Medicine

      Modal title

      Also from this source

      耶鲁大学医学院获捐 1,000 万美元,推进 1 型糖尿病治愈研究

      耶鲁大学医学院获捐 1,000 万美元,推进 1 型糖尿病治愈研究

      耶鲁大学医学院获得一笔 1,000 万美元捐款,将资助一项由多名研究人员共同参与、为期 5 年的研究计划,致力于逆转 1 型糖尿病,并以最终治愈疾病为目标。 这笔捐款由 Anastasia 和 Igor Bukhman 通过 Bukhman Foundation 捐赠。 耶鲁大学医学院 Jean...

      耶魯大學醫學院獲捐 1,000 萬美元,推動第一型糖尿病治癒研究

      耶魯大學醫學院獲捐 1,000 萬美元,推動第一型糖尿病治癒研究

      耶魯大學醫學院獲得一筆 1,000 萬美元捐款,將資助一項由多位研究人員共同參與、為期 5 年的研究計畫,致力於逆轉第一型糖尿病,並以最終治癒疾病為目標。 這筆捐款由 Anastasia 與 Igor Bukhman 透過 Bukhman Foundation 捐贈。 耶魯大學醫學院 Jean...

      More Releases From This Source

      Explore

      Education

      Education

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.